In 2021, the epigenetics industry was worth around USD 1,563.8 million, and it is projected to advance at a 17.1% CAGR from 2021 to 2030, hitting USD 6,460.5 million by 2030, according to P&S Intelligence. The fast technological expansions and their real-time acceptance by end users have formed profitable opportunities for key businesses within the whole molecular diagnostics biosphere. The … Continua a leggere→